Company Chabiotech Co.,Ltd.

Equities

A085660

KR7085660009

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
16,950 ^KRW	+0.36%		+1.25%	-13.48%

Jan. 08	CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy	MT
2023	CHA Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Chabiotech Co.,Ltd. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.

Number of employees: 312

KRW in Million	2022	Weight	2023	Weight	Delta
Healthcare 94.1 %	800,975	94.8 %	897,678	94.1 %	+12.07%
Other 4.7 %	40,470	4.8 %	44,363	4.7 %	+9.62%
Finance 1.2 %	3,138	0.4 %	11,910	1.2 %	+279.56%

KRW in Million	2022	Weight	2023	Weight	Delta
United States 66.6 %	591,039	70.0 %	635,108	66.6 %	+7.46%
South Korea 26.3 %	195,618	23.2 %	251,278	26.3 %	+28.45%
Singapore 6.8 %	57,410	6.8 %	64,804	6.8 %	+12.88%
Japan 0.3 %	516	0.1 %	2,762	0.3 %	+435.69%

Managers	Title	Age	Since
Sang-Hoon Oh CEO	Chief Executive Officer	60	19-02-28
Dong-Joon Lee DFI	Director of Finance/CFO	53	19-03-31
Jong-Guk Song PSD	President	63	05-12-31
Kyung-Eun Kim CTO	Chief Tech/Sci/R&D Officer	56	-
Hun Hwang IRC	Investor Relations Contact	51	19-08-31
Yeon-Jin Choi SAM	Sales & Marketing	51	-
Hyung-Sung Kim LAW	General Counsel	50	18-10-31
Chang-Ho Kim AUD	Comptroller/Controller/Auditor	70	17-03-15
Byeong-Woo Moon PRN	Corporate Officer/Principal	71	08-04-30

Members of the board	Title	Age	Since
Sang-kyu Lee BRD	Director/Board Member	72	-
Jong-Guk Song PSD	President	63	05-12-31
Joong-Ho Kim BRD	Director/Board Member	81	08-04-30
Yoon-Sang Park BRD	Director/Board Member	64	18-02-28
Il-Mo Kang BRD	Director/Board Member	72	18-02-28
Sang-Hoon Oh CEO	Chief Executive Officer	60	19-02-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	56,314,443	38,955,194 ( 69.17 %)	0	69.17 %

Name	Equities	%	Valuation
Kwang Yul Cha 16.11 %	9,069,572	16.11 %	112 M ₩
Won-Tae Cha 4.488 %	2,527,392	4.488 %	31 M ₩
Sung Kwang Academy 3.867 %	2,177,903	3.867 %	27 M ₩
Won-young Cha 2.259 %	1,272,298	2.259 %	16 M ₩
Won-hee Cha 1.848 %	1,040,513	1.848 %	13 M ₩
Hye-sook Kim 0.9024 %	508,166	0.9024 %	6 M ₩
Sung Kwang Medical Foundation 0.8614 %	485,115	0.8614 %	6 M ₩
Chacares Co., Ltd. 0.2936 %	165,331	0.2936 %	2 M ₩
Sewon Medical Foundation 0.2262 %	127,362	0.2262 %	2 M ₩
CHA-MEDITECH CO., LTD. 0.2045 %	115,146	0.2045 %	1 M ₩

Name	Equities	%	Valuation
CMG PHARMACEUTICAL CO., LTD. 25.84%	35,886,553	25.84%	54,916,474 $
CHA VACCINE RESEARCH INSTITUTE 38.37%	10,289,296	38.37%	36,925,608 $

Cha Biotech Co., Ltd.

3/F, Pie'n Polus Building 442 Dosan-daero

06062, Seoul

http://www.chabio.co.kr

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
CHABIOTECH CO.,LTD.	-13.48%	709M
MODERNA, INC.	+33.37%	50.85B
IQVIA HOLDINGS INC.	+1.55%	42.82B
LONZA GROUP AG	+49.17%	42.03B
CELLTRION, INC.	-4.22%	29.55B
ICON PUBLIC LIMITED COMPANY	+11.57%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-21.00%	19.13B
BIO-TECHNE CORPORATION	+7.36%	13.05B
MEDPACE HOLDINGS, INC.	+28.30%	12.16B
UNITED THERAPEUTICS CORPORATION	+23.80%	12.08B

Other Biotechnology & Medical Research